By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Identifying and advancing transformative medicines to treat patients120.7M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Europe, Middle East, and Africa (EMEA)132.03M59.50%
Asia-Pacific (APAC)76.56M34.50%
North America13.31M6.00%